Sobi
Sobi is seeking a Senior Medical Science Liaison specializing in Lymphoma to serve as a field-based scientific expert on cutaneous T-cell lymphoma and lacutamab. The role involves building trusted relationships with healthcare professionals, exchanging balanced medical information, and generating actionable insights to inform US Medical Affairs strategy. This position supports the rare disease portfolio in the hematology franchise and contributes to launch readiness and evidence generation activities.
Headquarters
Stockholm, Stockholm, Sweden
Company Size
1001-5000 employees
Founded
2009
Sobi is a specialised international biopharmaceutical company focused on transforming the lives of people with rare diseases by developing and delivering innovative medicines. The company invests heavily in R&D and maintains a strong pipeline, with expanded patient access and commercialization as core priorities. Headquartered in Stockholm, Sobi operates globally and partners with healthcare providers, patient communities and other stakeholders to bring novel therapies to market. It also emphasizes sustainability, transparency and investor engagement as part of its long‑term strategy.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Sobi.
Provisional Fellow (Lymphoma), Haematology
St Vincent's Hospital Melbourne
Associate Director, Field Medical Affairs, Cutaneous Oncology
Regeneron Pharmaceuticals
Assistant Professor (term) - Pediatric Hematology Oncology
University of Louisville
Cell Therapy Medical Onboarding Liaison (MOL) - East
Bristol Myers Squibb
Vice President or Sr. Vice President, Head of Medical Affairs
Lyell Immunopharma
Senior Medical Science Liaison – Cell Therapy (Kentucky, Ohio, and Tennessee)
AstraZeneca